Balance Sheet

v3.24.3

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 578,157	$ 574,962
Accounts receivable, net	28,873	54,605
Inventory	50,409	51,397
Prepaid expenses and other current assets	21,659	18,948
Total current assets	679,098	699,912
Property and equipment, net	164,555	162,900
Goodwill	171,790	326,029
Intangible assets, net	201,858	220,987
Other assets	60,914	77,622
Total assets	1,278,215	1,487,450
Current liabilities:
Accrued expenses and other current liabilities	38,498	60,237
Deferred revenue	1,834	3,360
Current portion of long-term debt	5,440	5,440
Current portion of finance lease liabilities	750	633
Total current liabilities	63,241	87,468
Long-term debt, less current portion	516,283	518,707
Finance lease liabilities, less current portion	31,327	31,897
Other long-term liabilities	54,237	59,494
Total liabilities	665,088	697,566
Commitments and contingencies (Note 7)
Stockholders’ equity:
Additional paid-in capital	175,581	128,503
Retained earnings	167,036	285,737
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc.	345,140	416,753
Non-controlling interest	267,987	373,131
Total stockholders’ equity	613,127	789,884
Total liabilities and stockholders’ equity	1,278,215	1,487,450
Class A Common Stock
Stockholders’ equity:
Common stock	1,416	1,322
Class B Common Stock
Stockholders’ equity:
Common stock	1,107	1,191
Nonrelated Party
Current liabilities:
Accounts payable	9,494	10,729
Related Party
Current liabilities:
Accounts payable	$ 7,225	$ 7,069

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source